Jan Tkadlec
Overview
Explore the profile of Jan Tkadlec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smelikova E, Krutova M, capek V, Brajerova M, Drevinek P, Tkadlec J
Ecotoxicol Environ Saf
. 2025 Jan;
289():117624.
PMID: 39752915
Public transport represents a potential site for the transmission of resistant pathogens due to the rapid movement of large numbers of people. This study aimed to investigate the bacterial contamination...
2.
Papouskova A, Drabkova Z, Brajerova M, Krutova M, Cizek A, Tkadlec J
J Antimicrob Chemother
. 2024 Aug;
79(11):2901-2905.
PMID: 39212167
Objectives: We performed a retrospective analysis of MRSA isolates collected at the university equine clinic including clinical isolates from 2008 to 2021 and screening environmental, equine and personnel isolates from...
3.
Kantor J, Tkadlec J, Hurych J, Vaculova M, Antuskova M, Lzicarova D, et al.
Folia Microbiol (Praha)
. 2024 Apr;
69(3):693-696.
PMID: 38625660
Following the COVID-19 infection, the sternum dislocation and wound dehiscence resulted in an infection complicating the recovery of an immunosuppressed patient after bilateral lung transplantation. Anaerobic culture (96 h) of...
4.
Tkadlec J, Prasilova J, Drevinek P
Microbiol Spectr
. 2023 Oct;
11(6):e0221423.
PMID: 37791769
No abstract available.
5.
Nag S, Larsen G, Szarvas J, Birkedahl L, Gulyas G, Ciok W, et al.
Sci Data
. 2023 Sep;
10(1):628.
PMID: 37717051
The Two Weeks in the World research project has resulted in a dataset of 3087 clinically relevant bacterial genomes with pertaining metadata, collected from 59 diagnostic units in 35 countries...
6.
Okwu M, Akpoka A, Mitsan O, Izevbuwa O, Osamede A, Tkadlec J
Microb Drug Resist
. 2023 Sep;
29(11):516-522.
PMID: 37713290
is one of the most common bacterial pathogens, often asymptomatically colonizing healthy people, but capable of causing fatal disease. The ability to treat infections is limited by the rapid spread...
7.
Tkadlec J, Le A, Brajerova M, Soltesova A, Marcisin J, Drevinek P, et al.
Microbiol Spectr
. 2023 Jun;
11(4):e0126423.
PMID: 37341582
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of health care-associated infections. Additionally, over the decades, the spread of community-associated (CA-MRSA) clones has become a serious problem. The aim of...
8.
Nurjadi D, Tkadlec J, Boutin S, Vandenesch F
Front Cell Infect Microbiol
. 2023 Jun;
13:1209671.
PMID: 37265498
No abstract available.
9.
Smelikova E, Tkadlec J, Krutova M
Klin Mikrobiol Infekc Lek
. 2022 Feb;
27(4):128-134.
PMID: 35220572
Background: Colistin is a last-resort antibiotic used for the treatment of infections caused by multidrug-resistant Gram-negative pathogens. The emergence of plasmid-borne colistin resistance mediated by the mcr genes poses a...
10.
Smelikova E, Tkadlec J, Krutova M
Clin Microbiol Infect
. 2021 Sep;
28(1):43-50.
PMID: 34537365
Background: Colistin belongs to the last-resort antibiotics. The discovery of plasmid-bound colistin resistance mediated by the mcr-gene(s) is of great concern because, given its biological potential, there is a risk...